Dow spikes 912 points as vaccine progress spurs economic-reopening optimism

Business Insider

Published

· *US stocks surged on Monday as Moderna announced that its coronavirus vaccine candidate had shown encouraging progress in a phase-one clinical trial.*
· *In a small number of healthy volunteers, Moderna's vaccine helped create immune responses that may help protect people from being infected with the novel coronavirus.*
·...

Full Article